Psoriatic Arthritis: A Dermatologist's Perspective
Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses the importance of early identification for patients with psoriatic arthritis as well as treatments that are currently available.
Insights Into Selecting Biologics for Psoriasis
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods…
Inside the New Psoriasis Guidelines, Part II
Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham, outlines select recommendations and the role dermatologists play in treating certain conditions.
Health Care Resource Use, Cost Burden Substantial for Psoriasis
Using Patient-Reported Outcomes to Select Psoriasis Biologics
ICER Identifies Need for More General Guidelines for Biologics Use in Psoriasis
Switching, Discontinuing Psoriasis Biologics Increases Medical Costs
Reduction in Health Care Costs With Psoriasis Treatment
Specialty Psoriasis Drugs Among Costliest to California Insurers
New Discovery May Yield Novel Therapies for Psoriasis
Psoriasis Therapy Discontinuation Rates
Lower QoL Among Patients With Chronic Rhinosinusitis With Nasal Polyps
Discussing Biosimilars: Barriers and Cost Effectiveness, Part 1
Use of a PCMH Model in an Employer-Based Worksite Clinic Lowers Costs, Improves Care
Predictive Score Categorizes Potentially Avoidable Readmission Risk
Understanding the Current Status of the ACA, Future of Health Care
Psoriatic Arthritis Excellence Forum
Psoriasis Excellence Forum
Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses the importance of early identification for patients with psoriatic arthritis as well as treatments that are currently…
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for patients.
Inside the New Psoriasis Guidelines, Part I
Alan Menter, MD, chairman of the division of dermatology at Baylor University Medical Center, Dallas, TX, and Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham and co-chair of the guideline workgroup, provide a…